135 related articles for article (PubMed ID: 36617507)
1. Hydrazone-Tethered 5-(Pyridin-4-yl)-4H-1,2,4-triazole-3-thiol Hybrids: Synthesis, Characterisation, in silico ADME Studies, and in vitro Antimycobacterial Evaluation and Cytotoxicity.
Oderinlo OO; Jordaan A; Seldon R; Isaacs M; Hoppe HC; Warner DF; Tukulula M; Khanye SD
ChemMedChem; 2023 Mar; 18(6):e202200572. PubMed ID: 36617507
[TBL] [Abstract][Full Text] [Related]
2. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
Jiang Y; Qian A; Li Y
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
[TBL] [Abstract][Full Text] [Related]
3. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities.
Ding Z; Hou P; Liu B
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087
[TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
5. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
[TBL] [Abstract][Full Text] [Related]
7. Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
Devi Bala B; Muthusaravanan S; Choon TS; Ashraf Ali M; Perumal S
Eur J Med Chem; 2014 Oct; 85():737-46. PubMed ID: 25129868
[TBL] [Abstract][Full Text] [Related]
8. Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment.
Zampieri D; Cateni F; Moneghini M; Zacchigna M; Laurini E; Marson D; De Logu A; Sanna A; Mamolo MG
Curr Top Med Chem; 2019; 19(8):620-632. PubMed ID: 30827247
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
[TBL] [Abstract][Full Text] [Related]
10. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
11. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis.
Rode ND; Sonawane AD; Nawale L; Khedkar VM; Joshi RA; Likhite AP; Sarkar D; Joshi RR
Chem Biol Drug Des; 2017 Dec; 90(6):1206-1214. PubMed ID: 28609019
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures.
Nyoni NTP; Ncube NB; Kubheka MX; Mkhwanazi NP; Senzani S; Singh T; Tukulula M
Bioorg Chem; 2023 Dec; 141():106904. PubMed ID: 37832224
[TBL] [Abstract][Full Text] [Related]
16. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
[TBL] [Abstract][Full Text] [Related]
17. Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agents.
Cao Y; Lu H
Future Med Chem; 2021 Dec; 13(23):2107-2124. PubMed ID: 34698509
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of some 4-arylidenamino-4H-1,2,4-triazole-3-thiols and their antituberculosis activity.
Ozdemir A; Turan-Zitouni G; Kaplancikli ZA; Chevallet P
J Enzyme Inhib Med Chem; 2007 Aug; 22(4):511-6. PubMed ID: 17847720
[TBL] [Abstract][Full Text] [Related]
20. Triazole derivatives and their anti-tubercular activity.
Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
